Categories
Sun Pharma Advanced Research Company Limited — Important, 25-05-2026: Updates
25-05-2026 · 08:39 pm
SPARC received ~₹1500 Cr from Shanghvi Finance for a preferential allotment of 3.85 Cr warrants. This significant capital infusion boosts SPARC's financial strength, paving the way for future strategic advancements.
No comments yet. Be the first to comment!
All announcements from Sun Pharma Advanced Research Company Limited